4.6 Article

Q61 mutant-mediated dynamics changes of the GTP-KRAS complex probed by Gaussian accelerated molecular dynamics and free energy landscapes

Journal

RSC ADVANCES
Volume 12, Issue 3, Pages 1742-1757

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/d1ra07936k

Keywords

-

Funding

  1. National Natural Science Foundation of China [11504206]
  2. Shandong Provincial Natural Science Foundation [ZR2021MA069, ZR2017MA040, ZR2020ME231]
  3. Key Research and Development Project of Shandong province [2019GGX102050]

Ask authors/readers for more resources

By simulating the effects of Q61A, Q61H, and Q61L on the activity of KRAS, this study reveals that these mutations cause structural disorder of the switch domain and disrupt the activity of KRAS. The findings provide valuable information for understanding the function and target roles of KRAS, which can guide the development of anti-cancer drugs.
Understanding the molecular mechanism of the GTP-KRAS binding is significant for improving the target roles of KRAS in cancer treatment. In this work, multiple replica Gaussian accelerated molecular dynamics (MR-GaMD) simulations were applied to decode the effect of Q61A, Q61H and Q61L on the activity of KRAS. Dynamics analyses based on MR-GaMD trajectory reveal that motion modes and dynamics behavior of the switch domain in KRAS are heavily affected by the three Q61 mutants. Information of free energy landscapes (FELs) shows that Q61A, Q61H and Q61L induce structural disorder of the switch domain and disturb the activity of KRAS. Analysis of the interaction network uncovers that the decrease in the stability of hydrogen bonding interactions (HBIs) of GTP with residues V29 and D30 induced by Q61A, Q61H and Q61L is responsible for the structural disorder of the switch-I and that in the occupancy of the hydrogen bond between GTP and residue G60 leads to the structural disorder of the switch-II. Thus, the high disorder of the switch domain caused by three current Q61 mutants produces a significant effect on binding of KRAS to its effectors. This work is expected to provide useful information for further understanding function and target roles of KRAS in anti-cancer drug development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available